Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05512208
Title A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib (DURAFAK)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST